Report Detail
COVID-19 Impact on Global Prescription Gastrointestinal Drugs Market Insights, Forecast to 2026
- RnM3984860 |
- 03 June, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Prescription Gastrointestinal Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Prescription Gastrointestinal Drugs industry.
Based on our recent survey, we have several different scenarios about the Prescription Gastrointestinal Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Prescription Gastrointestinal Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Gastrointestinal Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Gastrointestinal Drugs market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Prescription Gastrointestinal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Prescription Gastrointestinal Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Prescription Gastrointestinal Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Prescription Gastrointestinal Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Gastrointestinal Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Gastrointestinal Drugs market.
The following manufacturers are covered in this report:
AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals
...
Prescription Gastrointestinal Drugs Breakdown Data by Type
Oral
Topical
Prescription Gastrointestinal Drugs Breakdown Data by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
1 Study Coverage
- 1.1 Prescription Gastrointestinal Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Prescription Gastrointestinal Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Prescription Gastrointestinal Drugs Market Size Growth Rate by Type
- 1.4.2 Oral
- 1.4.3 Topical
- 1.5 Market by Application
- 1.5.1 Global Prescription Gastrointestinal Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Online Pharmacies
- 1.5.4 Retail Pharmacies
- 1.6 Coronavirus Disease 2019 (Covid-19): Prescription Gastrointestinal Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Prescription Gastrointestinal Drugs Industry
- 1.6.1.1 Prescription Gastrointestinal Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Prescription Gastrointestinal Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Prescription Gastrointestinal Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Prescription Gastrointestinal Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Prescription Gastrointestinal Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Prescription Gastrointestinal Drugs Revenue 2015-2026
- 2.1.2 Global Prescription Gastrointestinal Drugs Sales 2015-2026
- 2.2 Prescription Gastrointestinal Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Prescription Gastrointestinal Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Prescription Gastrointestinal Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prescription Gastrointestinal Drugs Competitor Landscape by Players
- 3.1 Prescription Gastrointestinal Drugs Sales by Manufacturers
- 3.1.1 Prescription Gastrointestinal Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Prescription Gastrointestinal Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Prescription Gastrointestinal Drugs Revenue by Manufacturers
- 3.2.1 Prescription Gastrointestinal Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Prescription Gastrointestinal Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Prescription Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Prescription Gastrointestinal Drugs Revenue in 2019
- 3.2.5 Global Prescription Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Prescription Gastrointestinal Drugs Price by Manufacturers
- 3.4 Prescription Gastrointestinal Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Prescription Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Prescription Gastrointestinal Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Prescription Gastrointestinal Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Prescription Gastrointestinal Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Prescription Gastrointestinal Drugs Sales by Type (2015-2020)
- 4.1.2 Global Prescription Gastrointestinal Drugs Revenue by Type (2015-2020)
- 4.1.3 Prescription Gastrointestinal Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Prescription Gastrointestinal Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Prescription Gastrointestinal Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Prescription Gastrointestinal Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Prescription Gastrointestinal Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Prescription Gastrointestinal Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Prescription Gastrointestinal Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Prescription Gastrointestinal Drugs Sales by Application (2015-2020)
- 5.1.2 Global Prescription Gastrointestinal Drugs Revenue by Application (2015-2020)
- 5.1.3 Prescription Gastrointestinal Drugs Price by Application (2015-2020)
- 5.2 Prescription Gastrointestinal Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Prescription Gastrointestinal Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Prescription Gastrointestinal Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Prescription Gastrointestinal Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Prescription Gastrointestinal Drugs by Country
- 6.1.1 North America Prescription Gastrointestinal Drugs Sales by Country
- 6.1.2 North America Prescription Gastrointestinal Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Prescription Gastrointestinal Drugs Market Facts & Figures by Type
- 6.3 North America Prescription Gastrointestinal Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Prescription Gastrointestinal Drugs by Country
- 7.1.1 Europe Prescription Gastrointestinal Drugs Sales by Country
- 7.1.2 Europe Prescription Gastrointestinal Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Prescription Gastrointestinal Drugs Market Facts & Figures by Type
- 7.3 Europe Prescription Gastrointestinal Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Prescription Gastrointestinal Drugs by Region
- 8.1.1 Asia Pacific Prescription Gastrointestinal Drugs Sales by Region
- 8.1.2 Asia Pacific Prescription Gastrointestinal Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Prescription Gastrointestinal Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Prescription Gastrointestinal Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Prescription Gastrointestinal Drugs by Country
- 9.1.1 Latin America Prescription Gastrointestinal Drugs Sales by Country
- 9.1.2 Latin America Prescription Gastrointestinal Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Prescription Gastrointestinal Drugs Market Facts & Figures by Type
- 9.3 Central & South America Prescription Gastrointestinal Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Prescription Gastrointestinal Drugs by Country
- 10.1.1 Middle East and Africa Prescription Gastrointestinal Drugs Sales by Country
- 10.1.2 Middle East and Africa Prescription Gastrointestinal Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Prescription Gastrointestinal Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Prescription Gastrointestinal Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Corporation Information
- 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AstraZeneca Prescription Gastrointestinal Drugs Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 Axcan Pharmaceuticals
- 11.2.1 Axcan Pharmaceuticals Corporation Information
- 11.2.2 Axcan Pharmaceuticals Description, Business Overview and Total Revenue
- 11.2.3 Axcan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Products Offered
- 11.2.5 Axcan Pharmaceuticals Recent Development
- 11.3 Eisai
- 11.3.1 Eisai Corporation Information
- 11.3.2 Eisai Description, Business Overview and Total Revenue
- 11.3.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Eisai Prescription Gastrointestinal Drugs Products Offered
- 11.3.5 Eisai Recent Development
- 11.4 GlaxoSmithKline
- 11.4.1 GlaxoSmithKline Corporation Information
- 11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Products Offered
- 11.4.5 GlaxoSmithKline Recent Development
- 11.5 Merck
- 11.5.1 Merck Corporation Information
- 11.5.2 Merck Description, Business Overview and Total Revenue
- 11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Merck Prescription Gastrointestinal Drugs Products Offered
- 11.5.5 Merck Recent Development
- 11.6 Salix Pharmaceuticals
- 11.6.1 Salix Pharmaceuticals Corporation Information
- 11.6.2 Salix Pharmaceuticals Description, Business Overview and Total Revenue
- 11.6.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Products Offered
- 11.6.5 Salix Pharmaceuticals Recent Development
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Corporation Information
- 11.1.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AstraZeneca Prescription Gastrointestinal Drugs Products Offered
- 11.1.5 AstraZeneca Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Prescription Gastrointestinal Drugs Market Estimates and Projections by Region
- 12.1.1 Global Prescription Gastrointestinal Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Prescription Gastrointestinal Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Prescription Gastrointestinal Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Prescription Gastrointestinal Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Prescription Gastrointestinal Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Prescription Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Prescription Gastrointestinal Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Prescription Gastrointestinal Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Prescription Gastrointestinal Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Prescription Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Prescription Gastrointestinal Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Prescription Gastrointestinal Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Prescription Gastrointestinal Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Prescription Gastrointestinal Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Prescription Gastrointestinal Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Prescription Gastrointestinal Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Prescription Gastrointestinal Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Prescription Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Prescription Gastrointestinal Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Prescription Gastrointestinal Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Prescription Gastrointestinal Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Prescription Gastrointestinal Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Prescription Gastrointestinal Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Prescription Gastrointestinal Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Prescription Gastrointestinal Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Prescription Gastrointestinal Drugs is a syndicated market report, published as COVID-19 Impact on Global Prescription Gastrointestinal Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Prescription Gastrointestinal Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
